No. 2 / 2025Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

No. 2 / 2025Correction includes 2024 Annual Report attached in iXBRL format. Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant clinical ...

Q4 2024 Earnings Call Transcript February 13, 2025 DexCom, Inc. misses on earnings expectations. Reported EPS is $0.45 EPS, expectations were $0.4792. Operator: Thank you for standing by. My name is ...

Annual Results/Quarter Results19-Feb-2025 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. Full-year ...

Researchers discovered that chronic intermittent ... Type 1 Diabetes: Hybrid Closed-Loop and Open-Loop Systems Compared Feb. 12, 2025 — People with type 1 diabetes require continuous insulin ...

The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the ...

Portfolio management, financial planning, trustee, responsible entity and compliance services, executor services, investment administration and custody services.